G01N 2800/102
Arthritis
Official title: Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
G01N2800/102 (Arthritis) appears on 372 US grants and 621 published applications in this corpus.
Search patents in G01N- Granted patents
- 372
- Published applications
- 621
- Assignees
- 433
- Inventors
- 1,425
- Latest grant
- 14 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 2 | 0 |
| 1986 | 2 | 0 |
| 1987 | 3 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 3 | 0 |
| 1991 | 3 | 0 |
| 1992 | 2 | 0 |
| 1993 | 6 | 0 |
| 1994 | 10 | 0 |
| 1995 | 6 | 0 |
| 1996 | 6 | 0 |
| 1997 | 11 | 0 |
| 1998 | 9 | 0 |
| 1999 | 10 | 0 |
| 2000 | 11 | 0 |
| 2001 | 3 | 1 |
| 2002 | 2 | 3 |
| 2003 | 9 | 15 |
| 2004 | 3 | 10 |
| 2005 | 7 | 13 |
| 2006 | 7 | 23 |
| 2007 | 5 | 23 |
| 2008 | 3 | 25 |
| 2009 | 5 | 29 |
| 2010 | 12 | 23 |
| 2011 | 16 | 47 |
| 2012 | 9 | 26 |
| 2013 | 12 | 34 |
| 2014 | 20 | 29 |
| 2015 | 14 | 32 |
| 2016 | 16 | 39 |
| 2017 | 16 | 36 |
| 2018 | 14 | 28 |
| 2019 | 16 | 25 |
| 2020 | 20 | 34 |
| 2021 | 14 | 29 |
| 2022 | 14 | 29 |
| 2023 | 14 | 21 |
| 2024 | 14 | 20 |
| 2025 | 10 | 16 |
| 2026 | 6 | 11 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods for predicting patient response to DMARDs14 Jul 2026US 12,681,015 B2Queen Mary University of London
- Biomarkers of early osteoarthritis16 Jun 2026US 12,656,343 B2CD Diagnostics, Inc.
- Method of diagnosing or prognosing psoriatic arthritis2 Jun 2026US 12,644,893 B2University College Dublin
- Biomarkers and uses therefor26 May 2026US 12,637,715 B2GenoDx Pty Ltd
- Assessing responsiveness of rheumatoid arthritis patients to biological treatment31 Mar 2026US 12,590,958 B2Navolab Diagnosztika Kft.
- Staining kit and method for assessing likelihood of rheumatoid arthritis disease risk using the same1 Oct 2026US 2026/0298923 A1
- Systems and methods for molecular endotyping of rheumatoid arthritis30 Jul 2026US 2026/0221227 A1AMPEL BioSolutions, LLC
- Method for selecting stem cells with enhanced cartilage differentiation capability and cell therapy product comprising same23 Jul 2026US 2026/0209709 A1
- Chondroitin Sulfate and Heparan Sulfate as Biomarkers for Discriminating Osteoarthritis and Rheumatoid Arthritis11 Jun 2026US 2026/0160757 A1Elypta AB
- Pharmacokinetic modeling systems for improved therapeutic dosing21 May 2026US 2026/0142011 A1Prometheus Laboratories Inc.
Most cited
By later US patents
- Method for identifying T cells disease involved in autoimmune disease97US 5,298,396 ANational Jewish Center for Immunology and Respiratory Medicine · 1994
- Therapeutic methods and agents for diseases associated with decreased expression of AOP-1 gene or AOP-193US 7,598,228 B2Asubio Pharma Co., Ltd. · 2009
- Method for diagnosing rheumatoid arthritis64US 5,395,753 ATheratech, Inc. · 1995
- Method for identifying T cells involved in autoimmune disease62US 5,776,708 ANational Jewish Center for Immunology and Respiratory Medicine · 1998
- Diagnostic reagents based on unique sequences within the variable region of the T cell receptor and uses thereof57US 4,886,743 ACalifornia Institute of Technology · 1989